Accessibility Menu
ResMed logo

ResMed(NYSE) RMD

Market Cap$32.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1995)+41,149%
5 Year-16%
1 Year-20%
1 Month+17%
Premium Feature
Moneyball Superscore
83/100
$231.66
+1.41%
+3.22Today
After hours$231.47-$0.19 (-0.08%)
ResMed last closing stock price
MetricPriceDate
Last closeUSD 228.442026-08-20
ResMed stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+1.04%USD 226.092026-08-13
1 month+17%USD 195.242026-07-21
3 month+10.12%USD 207.452026-05-22
Year to date-4.38%USD 238.922025-12-31
1 year-20.14%USD 286.032025-08-20
3 year+41.83%USD 161.072023-08-21
5 year-16.32%USD 273.002021-08-20
Since inception+41,148.95%USD 0.551995-06-02

ResMed Financials at a Glance

Market Cap

$32.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$5.65B

Net Income (TTM)

$1.52B

EPS (TTM)

$10.44

P/E Ratio

21.89

Dividend

$2.46

Beta (Volatility)

0.79 (Low)

Price

$231.66

Volume

1,725,346.911

Open

$229.44

Previous Close

$231.52

Daily Range

$228.54 - $234.14

52-Week Range

$180.27 - $293.81

Estimated Earnings Date

Oct 29, 2026

RMD News

Getty - peace of mind sleep at night financial security

3 Reasons Not to Sleep on ResMed Stock

Selena MaranjianMar 10, 2026
Copy of TMF YT Thumbnails (76)

ResMed: A Mixed Bag for Investors Amid Rising Competition

Motley Fool YouTubeJun 10, 2025
Lady with Sleep Apnea Mask

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

Royston YangMay 18, 2025
Sleep apnea_Medical device.jpg

ResMed: Digital Health Drives Q2 Growth

Motley Fool Markets TeamJan 30, 2025
woman sleeps with CPAP machine sleep apnea-1201x800-5b2df79.jpg

ResMed Tops Estimates in Fiscal 2025 Q1

Motley Fool Markets TeamOct 24, 2024
Medical professional with hand on head

Why ResMed Stock Tumbled by 5% Today

Eric VolkmanSep 18, 2024
CPAP mask person

Why ResMed Stock Is Soaring Today

Keith SpeightsApr 26, 2024
Lady Measuring Glucose Level

Got $1,000? Buy These Hot Growth Stocks Before They Take Off

Royston YangFeb 22, 2024
Page 1

RMD: Motley Fool Moneyball Superscore

83

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ResMed

ResMed Inc. makes devices for better sleep. These tools keep airways open during the night. The company also builds software for home healthcare.

Tools for Better Breathing

  • Sleep Health Devices: CPAP and bilevel machines for treating sleep apnea; generated $2.9 billion in net revenue during fiscal year 2026.
  • Masks and Accessories: Patient interfaces and related supplies for respiratory therapy; accounted for $2.1 billion in net revenue during fiscal year 2026.
  • Residential Care Software: Business management and electronic health record platforms for out-of-hospital providers; contributed $676 million in net revenue during fiscal year 2026.

Building the Future

  • Acquired VirtuOx in 2025 to expand in-home diagnostic testing services.
  • Bought Noctrix Health in June 2026 to add restless legs syndrome treatments.
  • Signed an agreement in June 2026 to sell the MatrixCare business for $490 million.
  • Partnered with OURA to connect sleep disturbance data with clinical resources.

Connected Care at Home

ResMed operates a global distribution network serving customers in more than 140 countries. The company integrates artificial intelligence and cloud connectivity into medical devices to track patient therapy adherence.

The Numbers for 2026

  • Net revenue rose 10% to $5.7 billion in fiscal year 2026.
  • Gross margin improved to 61.1% in fiscal year 2026, up from 59.4% in fiscal year 2025.
  • Net income reached $1.5 billion in fiscal year 2026, compared to $1.4 billion in fiscal year 2025.
  • Operating cash flow totaled $1.8 billion during fiscal year 2026.
  • The company paid $350 million in total dividends to stockholders during fiscal year 2026.

Final Outlook

ResMed has shifted from a hardware manufacturer to a digital health leader using cloud-connected solutions. Its focus on core sleep and breathing markets continues through strategic portfolio optimization.

AI Generated • Aug 14, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

11,370

CEO

Mick Farrell, MBA

Website

www.resmed.com

Headquarters

San Diego, CA 92123, US

RMD Financials

Key Financial Metrics (TTM)

Gross Margin

61.16%

Operating Margin

33.48%

Net Income Margin

26.94%

Return on Equity

23.88%

Return on Capital

25.54%

Return on Assets

16.99%

Earnings Yield

4.57%

Dividend Yield

1.08%

Payout Ratio

40.19%

Stock Overview

Market Cap

$32.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

144.25M

Volume

1.73M

Avg. Volume

1.54M

Financials (TTM)

Gross Profit

$3.46B

Operating Income

$1.89B

EBITDA

$2.15B

Operating Cash Flow

$3.16B

Capital Expenditure

-$267.46M

Free Cash Flow

$2.89B

Cash & ST Invst.

$1.47B

Total Debt

$825.92M

ResMed Performance Analysis

ResMed annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-06-30USD 4,222,993,00018.0%
20242024-06-30USD 4,685,297,00010.9%
20252025-06-30USD 5,146,327,0009.8%
20262026-06-30USD 5,653,443,0009.9%
ResMed sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30-0.9%
Q22025-12-316.5%
Q32026-03-310.6%
Q42026-06-302.3%
ResMed annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-06-30USD 6.0914.8%
20242024-06-30USD 6.9213.7%
20252025-06-30USD 9.5137.4%
20262026-06-30USD 10.439.7%
ResMed sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-09-30-8.1%
Q22025-12-3113.1%
Q32026-03-311.1%
Q42026-06-30-2.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

$1.46B

+8.6%

Gross Profit

$861.22M

+5.0%

Gross Margin

58.84%

N/A

Market Cap

$32.95BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.90M

N/A

Employees

11,370

N/A

Net Income

$383.43M

+1.0%

EBITDA

$492.96M

-7.4%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

$1.47B

+21.5%

Total Debt

$825.92M

-3.0%

Accounts Receivable

$1.04B

+4.6%

Inventory

$945.81M

+2.0%

Long Term Debt

$536.83M

-33.8%

Short Term Debt

$289.09M

+615.5%

Return on Assets

16.99%

N/A

Return on Invested Capital

25.00%

N/A

Free Cash Flow

$1.65B

+224.6%

Operating Cash Flow

$1.81B

+235.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GEHCGE HealthCare Technologies Inc.
$74.82+1.03%
ALCAlcon Inc.
$73.63+0.96%
MTDMettler-Toledo International Inc.
$1,395.25+0.14%
INSMInsmed Incorporated
$125.77+0.55%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$9.77+0.10%
IBITiShares Bitcoin Trust
$43.68+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$10.41+0.06%
MARAMara Holdings
$11.26+0.01%

Questions About RMD

What is the current price of ResMed?

ResMed is trading at $231.52 per share.

What is the 52-week range for ResMed?

Over the past 52 weeks, ResMed has traded between $180.27 and $293.81.

How much debt does ResMed have?

As of the most recent reporting period, ResMed reported total debt of $825.92M.

How much cash does ResMed have on hand?

ResMed reported $1.47B in cash and cash equivalents in its most recent financial results.

What is ResMed’s dividend yield?

ResMed currently has a dividend yield of 1.08%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services